Lixte Biotechnology Holdings, Inc.
Key Metrics
Market Snapshot
About
Lixte Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company developing cancer treatments targeting cancer signaling pathways. The company's research focuses on protein phosphatases and their role in cancer cell survival and proliferation. Lixte's lead drug candidates aim to inhibit specific pathways that tumors use to evade normal cellular controls. The company conducts clinical trials exploring its therapies for various cancer indications.